Amgen (NASDAQ:AMGN) resumed with Overweight rating and $280 (15% upside) price target at Morgan Stanley.
Hill-Rom Holdings (NYSE:HRC) upgraded to Overweight with a $138 (25% upside) price target at Morgan Stanley.
Johnson & Johnson (NYSE:JNJ) upgraded to Overweight with a $170 (20% upside) price target at Morgan Stanley. Shares up 1% premarket.
MedMen Enterprises (MMEN CN) upgraded to Market Perform at Cowen and Company.
Alexion Pharmaceuticals (NASDAQ:ALXN) downgraded to Equal Weight with a $128 (15% upside) price target at Morgan Stanley. Shares down 1% premarket.
Baxter International (NYSE:BAX) downgraded to Equal Weight with an $88 (5% upside) price target at Morgan Stanley. Shares down 1% premarket.
Galapagos NV (NASDAQ:GLPG) downgraded to Equal Weight at Morgan Stanley. Shares up 1% premarket.
Kala Pharmaceuticals (NASDAQ:KALA) downgraded to Neutral at BofA Merrill Lynch. Shares down 6% premarket.
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.